S-sulfocysteine is likely a normal excitatory neurotransmitter, acting as a sidekick to glutamate the way glycine and another sulfur compound, taurine, act as a sidekick to the main inhibitory neurotransmitter GABA
By binding to and activating the GLP-1 receptor, it mimics the natural incretin hormone GLP-1 to promote appetite suppression, delay gastric emptying, and increase insulin secretion while stabilizing glucose levels #Dapagliflozin (#Farxiga (US), #Forxiga (EU) by AstraZeneca) is an oral, once-daily SGLT2 inhibitor
Medications originally developed to manage type 2 diabetes and obesity are now the subject of rigorous clinical trials investigating their potential to treat addiction and the early results are generating serious optimism among researchers and clinicians alike
Following PSM, 3564 GLP-1 RAs users were matched with an equal number of nonusers
You eat less because of reduced appetite
The FDA has acknowledged this reality on the label itself: weight care requires ongoing therapy , and GLP-1 drugs are approved for chronic weight management only as an adjunct to diet and exercise they are not magic bullets that cure obesity after a few doses